Shin Kawamata

Shin KAWAMATA, MD, PhD
Director, Research and Development Center for Cell Therapy
Foundation for Biomedical Research and Innovation (FBRI)

[Shin Kawamata @KawamataShin]

我々の共同研究先である、シンフォニア・テクノロジー社の自動培養装置（CellQualia™）の実証実験が、英国医薬品・医療製品規制庁（MHRA）の下部組織であるUK Stem Cell Bank（略称：UKSCB）において開始されました。

以下、プレスリリースのリンク先です

https://t.co/VtNWnX9JnC

[Shin Kawamata @KawamataShin]

9月6日(火) 15時から、iPSポータル社オンラインセミナー「バイオエンジニアリングにおける人材育成」にて講演いたします。みなさま奮ってご参加ください。
（ご登録は以下からお願いします。）
https://t.co/WOfNVtfnQ9

[Shin Kawamata @KawamataShin]

This report gives new insights not only for optimum growth condition with biomarkers on PSC cell culturing, but also for new parameters of quality by design (QbD) on industrial PSC cell manufacturing.

[Shin Kawamata @KawamataShin]

We are pleased to announce that the paper "Improving the differentiation potential of pluripotent stem cells by optimizing culture conditions" by our research group of RDC, have just published on Scientific Report!
https://t.co/B5krT71PTu

[Shin Kawamata @KawamataShin]

以下イベントにて講演いたします。

第33回関西ライフサイエンス・リーディングサイエンティストセミナ―にて講演いたします。

2022/09/07（水）
講演1　14:00～15:00
「QbD に基づく細胞製剤製造の現状と展望」
【ハイブリッド開催】
詳細は以下より
https://t.co/ztrA9bujOv

[Shin Kawamata @KawamataShin]

第2回ロートフォーラムにて座長を致します。

日時：
Day 1－7月21日 ポスタ―セッション（日本時間15:00-16:00）

Day 2－7月22日 オンラインフォーラム（日本時間12：30－18：30）

オンライン（zoom）開催、参加登録無料！

講演内容、参加登録は以下まで
https://t.co/rKr1HzkE1O

[Shin Kawamata @KawamataShin]

以下ワークショップの後援をしております。お気軽にご参加ください。
第7回CSA関西・健康医療WG公開ワークショップ「バイオエコノミー産業のサイバーセキュリティ最新動向」
https://t.co/Ph0FiNVM4D
2022年7月27日（水） 1800-19:00
※Microsoft Teamsを使用するオンライン開催となります。

[Shin Kawamata @KawamataShin]

I will speak at an educational symposium (virtual) on “Recent Trends in Flow Cytometry Assays in Biopharma” at 4th July 2022 arranged by Becton Dickinson
From following link, you will access registration form.
https://t.co/fGvLp4MmZf

#FlowCytometry #immunotherapy #BioPharma

[Shin Kawamata @KawamataShin]

I am speaking at the 6th Cell & Gene Therapy World East Asia 2022, on 29 - 30 June 2022 at Songdo Convention Center, Incheon, South Korea.
https://t.co/9nXGABJJAb

[Shin Kawamata @KawamataShin]

EDB Singapore has been kind enough to visit us here.
#singapore ＃CellTharapy #CellandGeneTherapy

[Shin Kawamata @KawamataShin]

Thank you for coming to Kobe.
CEO of Treefrog, Frederic DESDOUITS visited from France.
Thank you!

[Shin Kawamata @KawamataShin]

I will speak at an educational symposium (virtual) on “Recent Trends in Flow Cytometry Assays in Biopharma” at 4th July 2022 arranged by Becton Dickinson

From following link, you will access registration form.
https://t.co/BZqOMr2ugv

#FlowCytometry #BioPharma #QualityControl

[Shin Kawamata @KawamataShin]

We propose to evaluate the cell legs on MSC to evaluate quality of MSC for standardization of cell culture in QbD concept.
#QbD #QualitybyDesign #MSC #CellPocket #manufacturing

[Shin Kawamata @KawamataShin]

I am speaking at the 6th Cell & Gene Therapy World East Asia 2022, on 29 - 30 June 2022 at Songdo Convention Center, Incheon, South Korea. Join us to witness the latest cell & gene therapy innovation
https://t.co/UNX5lqwlur

[Shin Kawamata @KawamataShin]

The overview of FBRI and our CPC. We are working as a CDMO. If you have any inquiry would you let us know.
https://t.co/v1fylwIH9f

#CPC #CellProcessing #CellTherapy #QbD #QualitybyTesting #InProcessMonitoring

[Shin Kawamata @KawamataShin]

For managing process, we need to define the appropriate parameter to monitor a quality of cells in process for recording. Regarding to expansion culture of iPS cells maintained self renewal potential, we'd like to propose to check Kynurenine.
https://t.co/RR1rfjT0dC

[Shin Kawamata @KawamataShin]

Future of automation for cell processing, we need to establish the pipeline to have information by IT base and to integrate diverse instruments in manufacturing site. Now we are developing software to manage the batch record in digital.

[Shin Kawamata @KawamataShin]

自動細胞培養装置 CellQualia ICP Systemの研究開発支援
https://t.co/B9gvJ1ObdR

[Shin Kawamata @KawamataShin]

We carries out manufactures cell-based products in facilities. To reduce the cost, the RDC is developing automated cell manufacturing system that can also increase output while assuring the quality of the product in collaboration with Symphonia.
https://t.co/vZIde1NPB4

[Italy in Osaka @ItalyinOsaka]

The 🇮🇹 Consul General in Osaka, Marco Prencipe, visited the KBIC (Kobe Biomedical Innovation Cluster - largest bio-medical cluster in Japan). KBIC includes 2 Riken research centers, 1 translational institute, 6 universities and colleges, 5 hospital and 380 biomedical companies.